LRRK2 and Parkinson disease: FC within striatal regions was investigated in N = 11 drug-naïve LRRK2-PD patients (R1628P and G2385R mutations carriers) compared to N = 11 drug-naïve sPD patients and N = 22 age-matched healthy controls using a seed-based approach.